Dynamics of volume transmission in the brain. Focus on catecholamine and opioid peptide communication and the role of uncoupling protein 2

Summary.This review focuses on transmitter-receptor mismatches in the brain, which is one of the hallmarks of the Volume Transmission (VT) concept, and how this phenomenon may be related to local temperature gradients created by brain uncoupling protein 2 (UCP2), which uncouples oxidative phosphorylation from ATP synthesis, hereby generating heat. Recent studies on transmitter-receptor mismatches have revealed dopamine and opioid peptide receptor mismatches in the intercalated islands of the amygdala, which are GABAergic cell clusters regulating amygdaloid output. Such mismatches have also been found in regions belonging to the extended amygdala and the nucleus accumbens shell. Now substantial UCP2 immunoreactivity has been found within the above transmitter-receptor mismatch regions, suggesting that UCP2 may enhance diffusion and convection of DA and opioid peptides in such regions by generation of local temperature gradients, thereby contributing to a dynamic regulation of VT.

[1]  J. Weissman,et al.  Volume Transmission in the Brain , 1992, Neurology.

[2]  K. Fuxe,et al.  Different classes of volume transmission signals exist in the central nervous system, and are affected by metabolic signals, temperature gradients, and pressure waves , 1994, Neuroreport.

[3]  C. Nicholson,et al.  Long distance pathways of diffusion for dextran along fibre bundles in brain. Relevance for volume transmission , 1995, Neuroreport.

[4]  R. Dantzer,et al.  Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS , 2000, Neuroscience.

[5]  T. Horvath,et al.  Brain Uncoupling Protein 2: Uncoupled Neuronal Mitochondria Predict Thermal Synapses in Homeostatic Centers , 1999, The Journal of Neuroscience.

[6]  C. Picó,et al.  The uncoupling protein, thermogenin. , 1998, The international journal of biochemistry & cell biology.

[7]  J. Weissenbach,et al.  Molecular approach to thermogenesis in brown adipose tissue: cDNA cloning of the mitochondrial uncoupling protein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. Fuxe,et al.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM. , 1965, Acta physiologica Scandinavica. Supplementum.

[9]  O. R. Blaumanis,et al.  Rapid solute transport throughout the brain via paravascular fluid pathways. , 1990, Advances in neurology.

[10]  A. Zhong,et al.  UCP4, a novel brain‐specific mitochondrial protein that reduces membrane potential in mammalian cells , 1999, FEBS letters.

[11]  R. Roth,et al.  Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease. , 2003, Endocrinology.

[12]  J. Stuart,et al.  Superoxide activates mitochondrial uncoupling proteins , 2002, Nature.

[13]  G. Alheid.  Amygdala and extended amygdala , 1995 .

[14]  M. Seldin,et al.  BMCP1, a Novel Mitochondrial Carrier with High Expression in the Central Nervous System of Humans and Rodents, and Respiration Uncoupling Activity in Recombinant Yeast* , 1998, The Journal of Biological Chemistry.

[15]  C. Aoki,et al.  Perikaryal and synaptic localization ofα 2A-adrenergic receptor-like immunoreactivity , 1994, Brain Research.

[16]  L. Descarries,et al.  Transmitter-Receptor Mismatches in Central Dopamine, Serotonin, and Neuropeptide Systems: Further Evidence for Volume Transmission , 2001 .

[17]  L. Descarries,et al.  Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: A quantitative autoradiographic and immunocytochemical analysis , 1996, The Journal of comparative neurology.

[18]  K. Fuxe,et al.  On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat , 1999, Neuroscience.

[19]  K. Fuxe,et al.  Uncoupling protein 2/3 immunoreactivity and the ascending dopaminergic and noradrenergic neuronal systems: Relevance for volume transmission , 2006, Neuroscience.

[20]  C. Barnstable,et al.  Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. , 2003, Endocrinology.

[21]  C. Aoki,et al.  Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity. , 1994, Brain research.

[22]  K. Fuxe,et al.  The dopamine D1 receptor-rich main and paracapsular intercalated nerve cell groups of the rat amygdala: relationship to the dopamine innervation , 2003, Neuroscience.

[23]  Stanley J. Watson,et al.  Immunohistochemical localization of the cloned μ opioid receptor in the rat CNS , 1995, Journal of Chemical Neuroanatomy.

[24]  J. Stamford,et al.  Spatiotemporal Interaction of α2 Autoreceptors and Noradrenaline Transporters in the Rat Locus Coeruleus , 2000, Journal of neurochemistry.

[25]  D. Pfaff,et al.  Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization , 1987, The Journal of comparative neurology.

[26]  K. Fuxe,et al.  Dopaminergic transmission in the rat retina: evidence for volume transmission , 1996, Journal of Chemical Neuroanatomy.

[27]  M. Herkenham,et al.  Studies of cerebrospinal fluid flow and penetration into brain following lateral ventricle and cisterna magna injections of the tracer [14C]inulin in rat , 1999, Neuroscience.

[28]  L. Agnati.  Volume transmission revisited , 2000 .

[29]  L. Descarries,et al.  Transmitter-Receptor Mismatches in Central Dopamine, Serotonin, and Neuropeptide Systems , 2002 .

[30]  J. Fallon,et al.  Distribution of dynorphin and enkephalin peptides in the rat brain , 1986, The Journal of comparative neurology.

[31]  O. E. Millhouse.  The intercalated cells of the amygdala , 1986, The Journal of comparative neurology.

[32]  C. Barnstable,et al.  Mitochondrial uncoupling protein 2 in the central nervous system: neuromodulator and neuroprotector. , 2003, Biochemical pharmacology.

[33]  M. Martres,et al.  Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain , 1995, Neuroscience.